ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,271.35
0.15%
Dow Jones
44,860.31
0.28%
Gold vs US Dollar
2,653.795
0.82%
Brent Oil
72.375
-0.10%
Bitcoin
93,185.61
1.32%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Virax Biolabs Group Ltd (VRAX)

  7. Virax Biolabs Group Ltd (VRAX) News

Virax Biolabs (VRAX)

Virax Biolabs Group Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VRAX
DateTimeSourceHeadlineSymbolCompany
20/11/202421:03Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:VRAXVirax Biolabs Group Ltd
31/10/202412:09Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:VRAXVirax Biolabs Group Ltd
23/10/202412:50Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:VRAXVirax Biolabs Group Ltd
23/10/202411:30PR Newswire (US)Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and IrelandNASDAQ:VRAXVirax Biolabs Group Ltd
30/09/202413:14Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:VRAXVirax Biolabs Group Ltd
30/09/202413:13Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:VRAXVirax Biolabs Group Ltd
16/09/202412:30PR Newswire (US)Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.NASDAQ:VRAXVirax Biolabs Group Ltd
09/09/202412:00PR Newswire (US)Virax Biolabs Presents at H.C. Wainwright's 26th Annual Global Investment ConferenceNASDAQ:VRAXVirax Biolabs Group Ltd
29/08/202413:03PR Newswire (US)Virax Biolabs to Participate at 7th European Congress of ImmunologyNASDAQ:VRAXVirax Biolabs Group Ltd
28/08/202411:30PR Newswire (US)Virax Biolabs Announces Distribution Agreement to Commercialize Mpox (formerly Monkeypox) Virus RT-PCR Detection Kits in Europe and the Middle EastNASDAQ:VRAXVirax Biolabs Group Ltd
23/08/202420:09PR Newswire (US)Virax Biolabs Group Limited Announces Closing of $5 Million Registered Direct Offering of Ordinary SharesNASDAQ:VRAXVirax Biolabs Group Ltd
23/08/202412:55Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:VRAXVirax Biolabs Group Ltd
23/08/202412:54Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:VRAXVirax Biolabs Group Ltd
22/08/202401:30PR Newswire (US)Virax Biolabs Group Limited Announces $5 Million Registered Direct Offering of Ordinary SharesNASDAQ:VRAXVirax Biolabs Group Ltd
20/08/202420:24Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:VRAXVirax Biolabs Group Ltd
01/08/202411:48Edgar (US Regulatory)Form NT 20-F - Notification of inability to timely file Form 20-FNASDAQ:VRAXVirax Biolabs Group Ltd
11/06/202420:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:VRAXVirax Biolabs Group Ltd
25/04/202412:00PR Newswire (US)Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024NASDAQ:VRAXVirax Biolabs Group Ltd
16/04/202411:30PR Newswire (US)Virax Biolabs to Participate at ESCMID Global 2024NASDAQ:VRAXVirax Biolabs Group Ltd
15/03/202420:30PR Newswire (US)Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price DeficiencyNASDAQ:VRAXVirax Biolabs Group Ltd
22/01/202422:28Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:VRAXVirax Biolabs Group Ltd
22/01/202422:27Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:VRAXVirax Biolabs Group Ltd
12/01/202412:43Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:VRAXVirax Biolabs Group Ltd
21/12/202312:34Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:VRAXVirax Biolabs Group Ltd
21/12/202312:30PR Newswire (US)Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID PatientsNASDAQ:VRAXVirax Biolabs Group Ltd
20/12/202321:12Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VRAXVirax Biolabs Group Ltd
20/12/202321:12Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VRAXVirax Biolabs Group Ltd
20/12/202321:06Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:VRAXVirax Biolabs Group Ltd
20/12/202321:03Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VRAXVirax Biolabs Group Ltd
18/12/202312:37Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:VRAXVirax Biolabs Group Ltd
 Showing the most relevant articles for your search:NASDAQ:VRAX

Your Recent History

LSE
SCLP
Scancell
LSE
VAST
Vast Resources
LSE
KEFI
Kefi Gold And Copper
LSE
EZJ
Easyjet
LSE
POS
Plexus
LSE
FRG
Firering Strategic Miner...
LSE
AAZ
Anglo Asian Mining
LSE
OMIP
One Media Ip
LSE
NFDS
Northern Foods
LSE
LLOY
Lloyds Banking
LSE
BARC
Barclays
LSE
ORCP
Oracle Power
LSE
DGI
Dg Innovate
LSE
JLP
Jubilee Metals
LSE
TERN
Tern
LSE
MIN
Minoan
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 60%* for Level 2 Lite

    1 year 35%, 2 years 45% and *3 years 60%

    *Across 3 years £2132.64 only £853.06